Page 9 - Cancer

AI detects gallbladder cancer as accurately as radiologists in India: Study

An artificial intelligence (AI) based approach demonstrated diagnostic performance comparable to experienced radiologists in detecting gall bladder cancer at a hospital in Chandigarh, according to a study published in The Lancet Regional Health Southeast Asia journal. Gallbladder cancer (GBC) is a highly aggressive malignancy with a poor detection and a high mortality rate. Early diagnosis is challenging because benign gallbladder lesions can have similar imaging features, the researchers said. The team at Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh and Indian Institute of Technology (IIT), New Delhi, aimed to develop and validate a deep learning (DL) model for GBC detection using abdominal ultrasound and compare its performance with radiologists. Deep learning is a method in AI that teaches computers to process data in a way that is inspired by the human brain. The study used abdominal ultrasound data from patients with gallbladder lesions ...

Cancer cases up 79% among under-50 in past 30 years, reveals study

In 2022, India recorded around 146,000 cancer cases, and projections indicate that this number is set to rise to 157,000 by 2025

AI-supported breast tumour screening found more cancers, finds study

Mammography screening supported by artificial intelligence (AI) detected one-fifth more breast cancers compared with standard screening and nearly halved the screen-reading workload for radiologists, new research published in The Lancet Oncology journal said. The findings conveyed the safety of AI-supported mammography, a diagnostic procedure for breast tumour screening, as an alternative to the conventional double reading by radiologists, the study led by Lund University, Sweden, said. Eighty-thousand Swedish women were recruited for the study and randomly allocated into two groups - an intervention group (40,003 women) that underwent AI-supported screening and a control group (40,030) that underwent standard screening. In total, 244 women (28 per cent) recalled from AI-supported screening were found to have cancer compared with 203 women (25 per cent) recalled from standard screening - resulting in 41 more cancer detections with the support of AI. "We found that using AI resulted

Short bursts of intense exercise linked to reduced risk of cancer: Study

Just 4-5 minutes of vigorous activity that makes people huff and puff during daily tasks is associated with a lower risk of some cancers by up to 32 per cent, according to a study. The research, published in the journal JAMA Oncology, used data from wearable devices to track the daily activity of over 22,000 'non-exercisers'. Researchers at the University of Sydney in Australia then followed the group's clinical health records for close to seven years to monitor for cancer. They found that four to five minutes of vigorous intermittent lifestyle physical activity or 'VILPA' was associated with a substantially lower cancer risk compared to those who undertook no VILPA. Short bursts of activity -- around one minute each -- includes activities like vigorous housework, carrying heavy shopping around the grocery store, bursts of power walking or playing high-energy games with the kids. Adults who don't exercise are at increased risk of developing certain cancers like breast, endometrial

SII manufactured BCG vaccine gets export nod to treat bladder cancer

The government has approved the export of BCG vaccine manufactured by the Serum Institute of India to Canada for immunotherapy to treat bladder cancer, official sources said on Monday. The permission was granted after Prakash Kumar Singh, director, Serum Institute, wrote to the Drugs Controller of India (DCGI) seeking approval to export BCG for immunotherapy to Canada, they said. BCG as immunotherapy is a live freeze-dried preparation derived from attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin). The product is for intravesical instillation and is available from the Serum Institute in 40 mg and 80 mg presentations, the sources said. As part of the therapy, the vaccine is administered into the bladder through a catheter where it stays in the lining of the bladder for a specific duration affecting the cells and fighting cancer without impacting other body parts.

Hospital employees arrested for referring patients to private labs

As many as 11 persons including a few employees of the Tata Memorial Hospital in the city have been arrested for allegedly referring cancer patients to private laboratories for commission, police said on Wednesday. The hospital, which comes under the purview of the Department of Atomic Energy, is known for advanced cancer treatment and research and gets patients from across the country. Some employees asked the patients to get diagnostic scans done at private imaging centres and laboratories, telling them that there was a long waiting period for scans in the hospital, said a police official. The accused included an assistant administrative officer, wardboy, aaya, servant and cleaning staff. They allegedly received commission from the private labs whose rates are higher than those at the hospital, the official said. The accused, thus, cheated the patients as well as the government to the tune of lakhs of rupees, he said. Based on a complaint filed by a hospital official, a First .

Johnson&Johnson ordered to pay $18.8 mn in California talc-cancer trial

Jurors in state court in state court in Oakland concluded Tuesday that J&J's baby powder helped cause Anthony Hernandez Valadez's mesothelioma, a specific type of cancer linked to asbestos exposure

What the WHO listing of aspartame means for the 'diet' soft drink habit

Aspartame is an artificial sweetener that is 200 times sweeter than sugar, but without any kilojoules

Cancer care should focus on patients rather than commerce: Lancet

Cancer care and innovation should be focused on outcomes that matter to patients rather than the commercial bottom line, say cancer experts in a Comment published in The Lancet Oncology journal. According to the Comment, industry's control of the research agenda has created a system that is predominantly focused on new cancer medicines at the expense of investigating new approaches to surgery, radiotherapy, palliative care, and prevention. The authors, consisting of global oncologists and patient advocates, also establish core guidelines for the development of a new patient-centred movement in cancer care - Common Sense Oncology. They claim that there has been a shift over the past few decades from predominantly publicly funded clinical trials designed to answer questions important to patients, to industry-funded trials which aim to achieve regulatory approval or commercial advantage. "While many cancer treatments make a real difference in the lives of our patients, there are growi

Aspartame under scanner: Is Diet Coke cancerous?

Aspartame, one of the most common artificial sweeteners in the world, is set to be declared a "possible carcinogen" by the World Health Organization's cancer research arm. Watch the video to know more

40% cancer cases caused by tobacco, alcohol; no clue in 20% cases: Expert

"The maximum number of patients of breast cancer and cervical cancer are found in women in urban areas. Cervical cancer patients are found more in rural areas than breast cancer patients"

New combination therapy cuts risk of breast cancer returning by 25%

The median duration of study follow-up was 34 months, with three-year and two-year duration of ribociclib completed by 20 per cent and 57 per cent patients respectively

Tata Memorial Centre aims to double share in cancer treatment by 2030

Tata Memorial Centre (TMC) is aiming to double its share of cancer patients it serves per year to 20 per cent of the total number of such patients in the country by 2030 from the present 10 per cent, its director Rajendra Badwe said on Friday. Currently, the centre provides treatment to 10 per cent of the country's total cancer patients per year. The premier cancer treatment and research institute, backed by Tata Group and the government, is expanding facilities and educational capabilities to train the manpower, which will be required to achieve the target, Badwe told reporters here. "Presently, India has about 13 lakh cancer patients every year, 10 per cent of those are treated at Tata Hospital. We would like that to be doubled to somewhere about 20 per cent of the total national problem," the director said, adding that the aim to double is being sought to be achieved by the end of the decade. He said the hospital feels there will be a huge increase in the total number of patient

AstraZeneca announces launch of cancer medication Tremelimumab in UAE

AstraZeneca has announced the launch of its revolutionary cancer medication, IMJUDO (tremelimumab) in the UAE

Pfizer pouring windfall profits from Covid-19 vaccine into cancer battle

The U.S. government will end the COVID Public Health Emergency on Thursday that allowed millions of Americans to receive vaccines, tests and treatments at no cost

Covid-19 dropped to fourth leading cause of death in US last year

U.S. deaths fell last year, and COVID-19 dropped to the nation's No. 4 cause, the Centers for Disease Control and Prevention reported Thursday. COVID-19 deaths trailed those caused by heart disease, cancer and injuries such as drug overdoses, motor vehicle fatalities and shootings. In 2020 and 2021, only heart disease and cancer were ahead of the coronavirus. U.S. deaths usually rise year-to-year, in part because the nation's population has been growing. The pandemic accelerated that trend, making 2021 the deadliest in U.S. history, with more than 3.4 million deaths. But 2022 saw the first drop in deaths since 2009. The 2022 tally was about 3.3 million a 5 per cent decline from 2021 but still much higher than in the years before the pandemic. The CDC cautioned that last year's numbers are preliminary and may change a little after further analysis. Coronavirus-associated death rates fell for nearly all Americans. The virus was deemed the underlying cause of about 187,000 U.S. death

Unleashing the potential of immunology to improve public health

.

J&J, cancer victims ordered to start settlement talks in bankruptcy

A federal judge ordered a new round of settlement talks between Johnson & Johnson and lawyers who spurned the company's offer to pay $8.9 billion to end tens of thousands of cancer claims

J&J accused by US of misusing bankruptcy to end talc cancer suits

J&J has an $8.9 billion settlement agreement with the "vast majority" of the law firms representing talc claimants, said the company's head of litigation

J&J accused by US of misusing bankruptcy to end talc cancer suits

The healthcare products maker is trying for the second time to get itself out of a jam as cheaply as possible, using the Chapter 11 filing of LTL Management